Ruhle Karl Heinz, Nilius Georg
Department of Pneumology, Allergology and Sleep Medicine, Klinik Ambrock, University Witten-Herdecke, Hagen, Germany.
Respiration. 2008;76(1):40-5. doi: 10.1159/000111806. Epub 2007 Nov 28.
Patients with obstructive sleep apnea syndrome (OSAS) often complain of dryness of mouth and throat prior to and during nasal continuous positive airway pressure (nCPAP). It is believed that this is due to mouth breathing (MB). However, the association between mouth breathing and apneas/hypopneas and the effect of CPAP on MB has not been studied.
The purpose of the present study was, therefore, to assess the frequency and duration of episodes of MB prior to and during treatment with nCPAP.
MB was recorded prior to and during nCPAP with a closely fitting mouth mask connected to a pneumotachograph and nasal flow was measured via nasal prongs. MB episodes were expressed as the number of events divided by total sleep time x 60, to give the MB event index per hour of sleep. MB time divided by total sleep time x 60 was calculated in minutes to get the MB time index per hour of sleep.
Eleven male patients with OSAS (mean age 57.9 +/- 8.3 years, body mass index 30.2 +/- 3.8) were recruited to the study.
Prior to nCPAP, the apnea/hypopnea index was 55.8 +/- 26 and decreased during nCPAP to 8.0 +/- 3.4. The lowest SaO2 measured was 82.9 +/- 4.7%, and increased to 87.5 +/- 2.7% under nCPAP. The mean nCPAP was 7.8 +/- 1.6 cm H2O. MB event index per hour of sleep decreased from 35.2 +/- 19.7 prior to treatment to 5.0 +/- 5.2 under nCPAP (p < 0.01). In 52.2 +/- 27.4% of obstructive respiratory events, MB started at the end of an apnea/hypopnea episode, decreasing to 8.5 +/- 12.5% with nCPAP treatment. MB time index per hour of sleep was reduced from 13.5 +/- 10.2 min prior to treatment to 4.6 +/- 5.5 min under nCPAP (p < 0.05).
In OSAS patients, MB episodes often appear at the termination of an apnea/hypopnea episode. In many cases, MB episodes can be markedly reduced by nCPAP treatment. When patients on nCPAP complain of dry mouth, appropriate measurements should be performed to verify MB.
阻塞性睡眠呼吸暂停综合征(OSAS)患者在接受鼻持续气道正压通气(nCPAP)治疗前及治疗期间常抱怨口干和咽干。人们认为这是由于口呼吸(MB)所致。然而,口呼吸与呼吸暂停/低通气之间的关联以及CPAP对口呼吸的影响尚未得到研究。
因此,本研究的目的是评估nCPAP治疗前及治疗期间口呼吸发作的频率和持续时间。
使用连接到呼吸流速计的紧密贴合的口罩在nCPAP治疗前及治疗期间记录口呼吸情况,并通过鼻夹测量鼻气流。口呼吸发作次数表示为发作次数除以总睡眠时间×60,得出每小时睡眠的口呼吸事件指数。口呼吸时间除以总睡眠时间×60,以分钟计算得出每小时睡眠的口呼吸时间指数。
招募了11名男性OSAS患者(平均年龄57.9±8.3岁,体重指数30.2±3.8)参与本研究。
在nCPAP治疗前,呼吸暂停/低通气指数为55.8±26,在nCPAP治疗期间降至8.0±3.4。测得的最低血氧饱和度(SaO2)为82.9±4.7%,在nCPAP治疗下升至87.5±2.7%。平均nCPAP压力为7.8±1.6厘米水柱。每小时睡眠的口呼吸事件指数从治疗前的35.2±19.7降至nCPAP治疗下的5.0±5.2(p<0.01)。在52.2±27.4%的阻塞性呼吸事件中,口呼吸在呼吸暂停/低通气发作结束时开始,在nCPAP治疗后降至8.5±12.5%。每小时睡眠的口呼吸时间指数从治疗前的13.5±10.2分钟降至nCPAP治疗下的4.6±5.5分钟(p<0.05)。
在OSAS患者中,口呼吸发作常出现在呼吸暂停/低通气发作结束时。在许多情况下,nCPAP治疗可显著减少口呼吸发作。当接受nCPAP治疗的患者抱怨口干时,应进行适当测量以核实口呼吸情况。